濟南高新(600807.SH)擬收購黃山藍田天香80%股權 參與田園綜合體PPP項目
格隆匯3月1日丨濟南高新(600807.SH)公佈,公司及控股子公司旺盛生態環境股份有限公司(簡稱“旺盛生態”)擬收購黃山藍田天香農業科技發展有限公司(簡稱“黃山藍田天香”或“項目公司”)80%股權,其中,旺盛生態收購60%股權,公司收購20%股權,以上股權轉讓款0元。旺盛生態在股權變更登記之日起30日內繳納註冊資本金2196萬元,剩餘註冊資本金由公司和旺盛生態分期繳足。
公司及旺盛生態收購黃山藍田天香股權後,將概括承繼原股東在《安徽省黃山市歙縣藍田·桃源田園綜合體PPP項目合同》中的所有權利和義務,該項目估算總投資約為6.10億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.